Implementing Pharmaceutical Drug Information Hotline Routing with Adverse Event Reporting
What This Guide Covers
This guide details the configuration of a Genesys Cloud CX contact center flow designed to route pharmaceutical drug information inquiries and distinguish them from medical adverse event reports. The end result is a production-ready call flow that captures specific data fields required for regulatory compliance, routes high-severity adverse events to specialized pharmacovigilance queues, and integrates securely with external safety reporting systems via API.
Prerequisites, Roles & Licensing
Before implementing this architecture, verify the following environment requirements. This solution requires Genesys Cloud CX Enterprise licensing to access advanced Data Actions and HTTP Request capabilities required for secure data transmission.
Licensing Requirements:
- Genesys Cloud CX Platform: Enterprise tier is mandatory. Basic or Connect tiers lack the necessary permissions for
Data Actionexecution within Architect flows for external integration. - WEM Add-on: Required if utilizing real-time adherence monitoring for pharmacovigilance agents to ensure SLAs are met for time-sensitive adverse event reports.
- API Access: External systems must allow inbound connections from Genesys Cloud IP ranges.
Granular Permissions:
The administrator account used to build this flow requires the following permission sets within the Admin Portal:
Telephony > Trunk > Edit(To configure SIP trunks if using on-prem gateway)Architect > Flow > Edit(Full access to build and publish flows)Data Actions > Execute(Permission to invoke custom data actions)API > OAuth > Client Credentials(To generate tokens for external system authentication)
OAuth Scopes:
When configuring the HTTP Request block for adverse event submission, the token generated must include these specific scopes:
pharmacovigilance:intake(Custom scope defined by your safety system vendor)contactcenter:api:read(To fetch customer history from Genesys)
External Dependencies:
- Pharmacovigilance System: A secure API endpoint capable of accepting JSON payloads compliant with FDA 21 CFR Part 11 requirements for electronic records.
- PII Masking Service: Optional but recommended middleware to scrub Protected Health Information (PHI) before it leaves the cloud environment if your organization policy mandates it.
The Implementation Deep-Dive
1. Architect Flow Design and Data Capture Strategy
The foundation of this solution lies in how data is collected during the interaction. You cannot rely on standard transcription for regulatory reporting because natural language processing accuracy varies, and speech recognition engines may not capture specific drug names or dosage information with 100% fidelity required for safety audits. The flow must use structured input collection (DTMF or guided dialog) to ensure data integrity.
Configuration Walkthrough:
- Create a new Architect Flow named
Pharmaceutical_Hotline_Adverse_Event_Routing. - Set the entry point type to Phone Call.
- Add a Get Customer Data block immediately after the greeting. Configure this to fetch the
phoneNumberand any stored profile attributes from the Genesys Cloud customer object. This establishes the audit trail for who initiated the call. - Implement a Play Prompt block that asks the caller to select their intent. Provide options:
- Press 1 for General Drug Information.
- Press 2 to report an Adverse Event or Safety Concern.
- Use a Capture Input block (Input Type: Number) to capture the selection. Store this result in a variable named
callIntent.
The Trap:
A common misconfiguration is relying on Voice AI or Speech Recognition engines to classify adverse events automatically without structured confirmation. If the system mishears “I had a reaction” as “No issues,” the call may be routed to a general queue, and the adverse event goes unreported. This creates a regulatory liability where the company lacks a record of the incident.
Corrective Action: Always require explicit DTMF input (Press 2) or a mandatory confirmation step before routing an adverse event. Do not rely solely on intent classification for safety-critical data.
Architectural Reasoning:
We use structured capture rather than natural language processing here because regulatory bodies like the FDA require precise documentation of the event details. Structured data collection ensures that the downstream system receives a standardized JSON payload rather than unstructured text notes. This reduces parsing errors in the Pharmacovigilance system and ensures every field required for Part 11 compliance is populated.
2. Routing Logic and Priority Queuing
Once the intent is captured, the flow must determine the destination based on risk severity. Adverse events require immediate attention from qualified staff, whereas general inquiries can be handled by lower-tier support agents. The routing logic must handle concurrent calls without queuing adverse event callers behind general inquiries.
Configuration Walkthrough:
- Add a Decision Tree block following the
Capture Inputstep. - Configure the condition to check if
callIntentequals2. - If true, route the call to the queue named
Queue_Adverse_Event_Specialists. - If false (general inquiry), route to
Queue_General_Drug_Info. - Configure the Queue settings for
Queue_Adverse_Event_Specialistswith a target answer speed of 30 seconds or less, compared to 60 seconds for general inquiries. - Enable Overflow Routing on the specialist queue to route to voicemail after 2 minutes if no agent is available, ensuring the caller receives an acknowledgment message about the adverse event submission status.
The Trap:
Engineers often configure a single shared queue with skill-based routing, assuming the system will prioritize based on agent status. In high-volume scenarios, general inquiries can fill the queue capacity, causing adverse events to sit in hold longer than the safety threshold allows. This delays critical reporting and may violate SLAs mandated by internal policy or external contracts.
Corrective Action: Always separate queues for critical vs. non-critical traffic. Use distinct routing strategies rather than relying on priority flags within a single queue object.
Architectural Reasoning:
Separating queues allows for different Service Level Agreements (SLAs) to be tracked independently in the Analytics dashboard. It also enables you to apply specific workforce management rules, such as ensuring that at least one pharmacovigilance specialist is always logged in during business hours, which is not feasible if they are mixed with generalists handling routine questions. This segregation ensures that the specialized agents can focus on data collection and validation without interruption.
3. Secure Data Submission via API Integration
The most critical technical component is the transmission of adverse event data to the external safety system. This must occur synchronously or asynchronously depending on your latency requirements, but it must be secure. You must ensure that no PII (Personally Identifiable Information) or PHI (Protected Health Information) is transmitted in plain text.
Configuration Walkthrough:
- Create a Data Action within Genesys Cloud CX named
Submit_Adverse_Event. - Define the input parameters for this action:
patientAge,drugName,eventDescription,reporterID, andcallID. - Inside the Architect Flow, add an Execute HTTP Request block after the decision logic confirms an adverse event.
- Set the method to POST.
- Set the URL to your external endpoint (e.g.,
https://api.safetyvendor.com/v2/report). - In the Headers, set
Content-Typetoapplication/json. - Construct the Body using JSON syntax with variables mapped from the previous steps:
{
"eventType": "Adverse_Event",
"severity": "Standard",
"patientId": "REDACTED",
"drugName": "{{var.drugName}}",
"details": "{{var.eventDescription}}",
"timestamp": "{{var.startTime}}",
"complianceTag": "FDA_21CFR_Part11"
}
- Add error handling logic to the HTTP Request block. If the status code is not
200, route the call to a supervisor queue and log the failure in an internal audit log table.
The Trap:
A frequent misconfiguration involves storing raw PII (like Social Security Numbers or full names) directly into the JSON payload for mapping purposes without encryption. Genesys Cloud CX encrypts data at rest, but passing clear-text PHI to a third-party API violates HIPAA and GDPR regulations if the destination does not have equivalent controls.
Corrective Action: Implement PII masking within the Data Action or use an intermediate middleware service that tokenizes sensitive fields before they reach the external vendor. Never store raw SSNs in the call variables used for API payloads unless the destination is verified to be HIPAA-compliant.
Architectural Reasoning:
We use a Genesys Cloud Data Action wrapper rather than a direct HTTP Request block for the payload construction because Data Actions provide an additional layer of auditability within the platform logs. They allow you to version control the API contract independently of the flow logic. If the external vendor changes their API schema, you can update the Data Action without republishing the entire Architect flow, reducing deployment risk and downtime. Furthermore, Data Actions allow for easier monitoring of API success rates in the Genesys Cloud Observability dashboard.
Validation, Edge Cases & Troubleshooting
Edge Case 1: API Timeout During Active Call
The Failure Condition: The HTTP Request block times out after 10 seconds while the caller is still on hold, resulting in a disconnect or an error message being played to the patient.
The Root Cause: Network latency between Genesys Cloud and the external vendor exceeds the default timeout threshold, or the vendor API is unresponsive due to maintenance.
The Solution: Configure a Timeout setting within the HTTP Request block to at least 30 seconds. More importantly, implement an error branch in the flow logic. If the request fails, do not disconnect. Instead, play a message stating “Your report has been received and will be processed” and route the call to a queue where agents can manually follow up. This ensures that no adverse event is lost due to technical latency.
Edge Case 2: False Positive Adverse Event Reporting
The Failure Condition: A caller presses ‘2’ for an adverse event but is actually asking about side effects listed on a brochure, which does not constitute a reportable safety incident.
The Root Cause: The IVR logic assumes all intent ‘2’ selections are critical events without further qualification.
The Solution: Add a secondary confirmation step in the flow before submitting data. After capturing intent ‘2’, play a prompt: “Please confirm if this is a new medical event or a known side effect inquiry.” If the user selects the latter, route to general info; if confirmed as an event, proceed to submission. This reduces noise in the safety database and prevents unnecessary regulatory filings for non-events.
Edge Case 3: Call Drop Before Data Capture
The Failure Condition: The caller disconnects after entering data but before the HTTP Request completes execution.
The Root Cause: Architect flows process synchronously during the call session. If the network drops, the flow terminates and the POST request is aborted.
The Solution: Implement an asynchronous pattern using a webhook or a background job trigger if your architecture supports it. In standard Genesys Cloud Architect, you must accept that data loss is possible on hard disconnects. To mitigate this, record the call for compliance purposes. The recording will contain the spoken data which can be used to reconstruct the event manually if the API failed. Ensure your Recording settings are enabled for all adverse event queues in the Compliance Configuration.
Official References
- Genesys Cloud Architect Documentation - Details on flow logic, blocks, and variables.
- Genesys Cloud Data Action API Reference - Technical specifications for creating and executing custom data actions.
- FDA 21 CFR Part 11: Electronic Records; Electronic Signatures - Regulatory requirements for electronic recordkeeping in pharmaceuticals.
- HIPAA Security Rule Summary - Guidelines for protecting Protected Health Information (PHI).